One of nine potential COVID-19 vaccines in a phase three trial has had a setback. AstraZeneca says it is pausing its vaccine study after the company revealed that a trial participant had a serious adverse reaction in the United Kingdom, as first reported by the health and medicine publication STAT.
Here & Now‘s Robin Young speaks with senior writer Adam Feuerstein.
This article was originally published on WBUR.org.
Copyright 2020 NPR. To see more, visit https://www.npr.org. 9(MDA5MTc0MDI0MDEzMzE4MjI4ODdlOTk4MA004))